Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?

Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?

Chronic obstructive pulmonary disease (COPD) is a major global cause of morbidity and mortality, projected to become the 3rd cause of disease mortality worldwide by 2020. COPD is characterized by persistent and not fully reversible airflow limitation that is usually progressive and is associated wit...

Full description

Bibliographic Details
Main Authors: Andrzej M. Janczewski, Joanna Wojtkiewicz, Ewa Malinowska, Anna Doboszyńska
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:International Journal of Molecular Sciences
Subjects:
chronic obstructive pulmonary disease
Wharton’s jelly
mesenchymal stem cells
anti-inflammatory effects
immunomodulation
therapeutic applications
Online Access:https://www.mdpi.com/1422-0067/18/11/2449

Similar Items

Similar Items